The effects of interleukin-6 neutralizing antibodies on symptoms of depressed mood and anhedonia in patients with rheumatoid arthritis and multicentric Castleman’s disease

References

Page 1

	Year	Citations
2010 Rheumatoid arthritis classification criteria: An American College of Rheumatology/European League Against Rheumatism collaborative initiative Daniel Aletaha, Tuhina Neogi, Alan J. Silman, Arthritis & Rheumatism	2010	9.3K
Molecular Adaptations Underlying Susceptibility and Resistance to Social Defeat in Brain Reward Regions Vaishnav Krishnan, Ming‐Hu Han, Danielle Graham, Cell Molecular AdaptationsNeurobiological MechanismMolecular NeuroscienceBehavioral NeuroscienceSocial Behavior	2007	2.3K
Essential Role of BDNF in the Mesolimbic Dopamine Pathway in Social Defeat Stress Olivier Berton, Colleen A. McClung, Ralph Dileone, Science Mesolimbic Dopamine PathwaySocial ContactPsychologySocial SciencesStress	2006	2.1K
A Randomized Controlled Trial of the Tumor Necrosis Factor Antagonist Infliximab for Treatment-Resistant Depression Charles L. Raison, Robin E. Rutherford, Bobbi J. Woolwine, JAMA Psychiatry	2012	1.5K
A standardized protocol for repeated social defeat stress in mice Sam A. Golden, Herbert E. Covington, Olivier Berton, Nature Protocols PsychoneuroimmunologyBehavioral SciencesStress PsychologyStress HormoneStandardized Protocol	2011	1.5K
Etanercept and clinical outcomes, fatigue, and depression in psoriasis: double-blind placebo-controlled randomised phase III trial Stephen K. Tyring, Alice B. Gottlieb, Kim Papp, The Lancet PsychiatryMedicineClinical TrialsDepressionClinical Dermatology	2005	1.1K
Individual differences in the peripheral immune system promote resilience versus susceptibility to social stress Georgia E. Hodes, Madeline L. Pfau, Marylène Leboeuf, Proceedings of the National Academy of Sciences	2014	684
β-Adrenergic Receptor Antagonism Prevents Anxiety-Like Behavior and Microglial Reactivity Induced by Repeated Social Defeat Eric S. Wohleb, Mark L. Hanke, Angela W. Corona, Journal of Neuroscience	2011	626
Increased plasma concentrations of interleukin-6, soluble interleukin-6, soluble interleukin-2 and transferrin receptor in major depression Michaël Maes, Herbert Y. Meltzer, Eugène Bosmans, Journal of Affective Disorders InflammationPlasma ConcentrationsPsychoneuroimmunologyStress HormonePsychiatry	1995	625
Interleukin-6 Is Elevated in the Cerebrospinal Fluid of Suicide Attempters and Related to Symptom Severity Daniel Lindqvist, Shorena Janelidze, Peter Hagell, Biological Psychiatry InflammationClinical DisordersPsychoneuroimmunologyPsychiatryMedicine	2009	512

Page 1